Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ:INBS)

0.6418 -0.0436 (-6.36%)
Streaming Delayed Price Updated: 2:16 PM EST, Nov 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Intelligent Bio Solutions Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Datavault AI (NASDAQ: DVLT) Powers Scilex Holding (NASDAQ: SCLX) with Exclusive License to Tokenize $2 Trillion in Biotech – Bonus Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Intellectual Property
BioMedNewsBreaks — Intelligent Bio Solutions Inc. (NASDAQ: INBS) Wins Major Contract With London Public Transport Operator
Via Investor Brand Network
Topics Cannabis
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Announces $3.8 Million Warrant Exercise Agreement
Via Investor Brand Network
Topics Cannabis
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Strengthens FDA 510(k) Submission With New Security and Performance Data
Via Investor Brand Network
Topics Cannabis
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Global Reach with SMARTOX Distribution Deal
Via Investor Brand Network
Topics Cannabis
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Non-Invasive Drug Testing Portfolio With SmarTest Patch
Via Investor Brand Network
Topics Cannabis
InvestorNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Present Fingerprint Sweat PK Study at ADLM 2025 Clinical Lab Expo
Via Investor Brand Network
Topics Cannabis
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands Fingerprint Drug Testing Across Scandinavia with Spjotgard Partnership
Via Investor Brand Network
Topics Cannabis
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) to Deploy Fingerprint Drug Testing System Across MWS Sites in Australia
Via Investor Brand Network
Topics Cannabis
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) CEO Highlights Fingerprint Drug Testing on BioMedWire Podcast
Via Investor Brand Network
Topics Cannabis
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (NASDAQ: INBS) Expands U.S. Forensic Market Presence Through SMARTOX Partnership
Via Investor Brand Network
Topics Cannabis
InvestorNewsBreaks – Why Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’
Via Investor Brand Network
Topics Cannabis
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 as U.S. Expansion Advances
Via Investor Brand Network
Topics Cannabis
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Progressing with FDA Clearance for Fingerprint Drug Testing as Global Demand Grows
Via Investor Brand Network
BioMedNewsBreaks — Intelligent Bio Solutions Inc. (Nasdaq: INBS) to Showcase Fingerprint Drug Testing at RISE25 Conference
Via Investor Brand Network
Topics Cannabis
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Targets Global Sales Growth with Multilingual Digital Rollout
Via Investor Brand Network
BioMedNewsBreaks — Intelligent Bio Solutions Inc. (NASDAQ: INBS) Surpasses 450 Accounts as Fingerprint Drug Testing Expands Globally
Via Investor Brand Network
Topics Cannabis
BioMedNewsBreaks – Intelligent Bio Solutions Inc. (Nasdaq: INBS) Grows Revenue, Cuts Losses in Fiscal Q3 as Cartridge Sales Drive Margins
Via Investor Brand Network
Topics Cannabis Intellectual Property
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’
Via Investor Brand Network
Topics Cannabis Intellectual Property
News headline image
iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025
Via ACCESS Newswire
News headline image
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Cannabis Death
Harry Simeonidis, CEO of Intelligent Bio Solutions Inc. (NASDAQ: INBS), to Present at NobleCon20
Via Investor Brand Network
News headline image
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
From FN Media Group LLC
Via GlobeNewswire
News headline image
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Intelligent Bio Solutions Partners With B2i Digital to Amplify Investor Outreach
NEW YORK - (NewMediaWire) - November 1, 2024 - Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing... 
Via TheNewswire.com
Stocks Driving Market Momentum with Groundbreaking Contracts and Technologies: LUNR, PRSO, LPTH, INBS, PNPN.V
Via AB Newswire
Topics Economy Emissions Energy
“Intelligent Bio (NASDAQ: INBS), SINTX Technologies (NASDAQ: SINT) Lead Market Surge, and Piedmont, Kaival, Peraso Show Strong Potential”
Via AB Newswire
Topics Intellectual Property
“Stocks to Watch Showing Strong Market Potential INBS, NANO.T, MLGO, KAVL, PNPN.V”
Via AB Newswire
Topics Artificial Intelligence
Growth Stocks Across Multiple Sectors-Innovators in Action: MODD, INBS, RCAT, KAVL, WHLR”
Via AB Newswire
Fit to Work: Intelligent Bio Solutions’ (NASDAQ: INBS) Vision for a Healthier, Safer Workplace WISA, BFLY, CLOV, PRSO
Via AB Newswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.